About: Synthalin

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s.

Property Value
dbo:abstract
  • Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s. (en)
dbo:iupacName
  • N,N′′′-(Decane-1,10-diyl)diguanidine (en)
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 25459834 (xsd:integer)
dbo:wikiPageLength
  • 4171 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1113573625 (xsd:integer)
dbo:wikiPageWikiLink
dbp:imagefile
  • Synthalin.svg (en)
dbp:imagename
  • Skeletal formula of synthalin (en)
dbp:pin
  • N,N′′′-diguanidine (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s. (en)
rdfs:label
  • Synthalin (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License